Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01424644Phase 4Completed
A Phase 4 trial of Meningococcal A, C, Y and W-135 conjugate vaccine in meningococcal meningitis, Tetanus, diphtheria, pertussis, human papillomavirus infection, sponsored by Novartis. Started Sep 2011; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01424644.